1+ hour, 43+ min ago  (605+ words) Posted by Kim Johansen on Mar 1st, 2026 Mehta referenced previously announced results from a Phase III pivotal study of BXCL501 for the acute treatment of agitation in Alzheimer's dementia, stating that the product candidate was well-tolerated and met its primary efficacy endpoint....

9+ hour, 37+ min ago  (335+ words) Posted by Danessa Lincoln on Mar 1st, 2026 On pharmacology, Fortney highlighted what she described as potential best-in-class potency, including an IC90 of 1.8 nM in a human ex vivo whole-blood stimulation assay. She said the company has shown 24-hour IC90 coverage at 60 mg once…...

1+ day, 1+ hour ago  (81+ words) Posted by Tristan Rich on Mar 1st, 2026 We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles…...

1+ day, 2+ hour ago  (593+ words) Posted by Sarita Garza on Feb 28th, 2026 Shah also noted the company is working on a preclinical program in Huntington's disease. In FA, Shah said patients produce normal frataxin, but at low levels due to abnormally long GAA repeats in the…...

1+ day, 5+ hour ago  (595+ words) Posted by Danessa Lincoln on Feb 28th, 2026 Climb Bio (NASDAQ:CLYM) outlined its strategy and upcoming clinical milestones during a fireside chat at Oppenheimer's 36th Annual Healthcare Life Sciences Conference, with Chief Medical Officer Edgar Charles and CFO Susan Altschuller joining analyst…...

1+ day, 6+ hour ago  (250+ words) Posted by Michael Walen on Feb 28th, 2026 Kymera Therapeutics (NASDAQ:KYMR) executives highlighted a sharpened strategic focus on immunology and inflammation at Oppenheimer's 36th Annual Healthcare Conference, emphasizing progress in its STAT6 degrader KT-621, the start of clinical dosing for its IRF5 program, and…...

1+ day, 21+ hour ago  (191+ words) Posted by Michael Walen on Feb 28th, 2026 Frakes explained that the Hemopurifier can be connected to existing blood-pumping infrastructure commonly found in hospitals and clinics worldwide, including dialysis machines, plasmapheresis machines, and CRRT systems. Treatment sessions are typically about four hours,…...

2+ day, 3+ hour ago  (75+ words) Posted by Tristan Rich on Feb 27th, 2026 FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression…...

3+ day, 8+ hour ago  (279+ words) Posted by Michael Walen on Feb 26th, 2026 He noted a formal OS interim analysis is planned for the beginning of 2027. In the discussion, Beaupre suggested that around 30% of OS events is a threshold at which stakeholders may begin to have more…...

4+ day, 11+ min ago  (387+ words) Posted by Kim Johansen on Feb 26th, 2026 Avalo's lead program, AVTX-009, is an anti-IL-1" monoclonal antibody being evaluated in moderate-to-severe HS. Neil described IL-1" as central to the inflammatory process in HS and highlighted the disease's neutrophilic features. He said HS lesions…...